Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this work is to evaluate the efficacy of adding alcohol to local anesthetics and steroids to provide pain relief in patients with sacroiliac joint pain.
Low back pain (LBP) is one of the most common health problems globally. According to the Global Burden of Disease (GBD) Study 2021, low back pain is the leading cause of years lived with disability worldwide. It affects approximately 619 million people globally, and this number is projected to increase to 843 million by 2050 due to population growth and aging. (1) LBP may arise from multiple anatomical structures, such as muscle, intervertebral disc, fascia, and facet joint. Another common cause of LBP includes the sacroiliac joint (SIJ). It is estimated that around 10-38% of LBP cases originated from the SIJ. (2) In addition to its prevalence, SIJ pain lacks valid clinical/diagnostic tests and no therapeutic modalities for long-term improvement have been found yet. (3) Treatment of SIJ pain is another dilemma, and a wide range of therapeutic modalities has been used, including pharmacotherapy, chiropractic manipulation, SIJ injection (local anesthetics, steroid, or mixture), and surgical fixation. (4) Steroid and local anesthetic (LA) injections are widely used for managing SIJ pain, and evidence supports their effectiveness, particularly in the short to intermediate term but long-term benefit usually requires repeat injections or alternative treatments as radiofrequency or prolotherapy (5,6,7) Recently, alcohol neurolysis has gained popularity and become a well-established interventional technique in pain management, particularly for patients with chronic or cancer-related pain that is refractory to conventional therapies. (8)
Alcohol (Ethanol) in different concentrations (from 70% to 20%) has been used in different joints and pain syndromes such as trigeminal neuralgia, post-mastectomy pain syndrome, ankle pain from Morton neuroma and bursitis, and it proved its efficacy and safety. (9,10,11,12) Previous studies tried phenol injection in SIJ pain which acts nearly with the same mechanism of action as ethanol exerting a neurolytic effect through protein denaturation and nerve fiber destruction. Also proved its efficacy and safety. (13, 14) No previous studies used alcohol injection in SIJ.This study hypothesize that the use of alcohol (ethanol) 30% as an adjuvant to steroids and local anesthetics in SIJ as a novel approach may offer both short and long-term pain relief and reduce the frequency of repeated injections.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental group (group A) | Experimental | receives a mixture of alcohol 30%, dexamethasone and lidocaine 2% |
|
| Active comparator group (group D) | Active Comparator | receives a mixture of dexamethasone and lidocaine 2% |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sacroiliac joint injection | Procedure | US-guided periarticular sacroiliac joint injection of a mixture of dexamethasone and lidocaine 2% |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain relief as measured by the visual analogue scale VAS scale | Presented by a 10 cm horizontal line representing the patient's pain intensity. Zero represents "no pain" while the upper limit (10 cm) represents the "worst pain imaginable. | preoperative(baseline), immediate after injection, 4 weeks, 8 weeks, 4 months and 6 months after injection |
| Measure | Description | Time Frame |
|---|---|---|
| Oswestry Disability Index (ODI) | is a questionnaire designed to assess the degree of disability in low back pain. It comprises 10 sections, pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sexual activity, social life, and traveling. Each section is scored on a scale from 0 to 5, the total score is calculated by summing section scores, dividing by the maximum possible score, and multiplying by 100 to yield a percentage from 0 to 100% .with higher percentages denoting more severe disability. The total score is the number of questions with a positive response (yes) and reduction in four or more scores indicates that the treatment has achieved its goal. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| FayoumU | Al Fayyum | Faiyum Governorate | Egypt |
Not provided
| ID | Term |
|---|---|
| D017116 | Low Back Pain |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D001416 | Back Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| sacroiliac joint injection | Procedure | US-guided periarticular sacroiliac joint injection of a mixture of alcohol 30%, dexamethasone and lidocaine 2% |
|
| preoperative(baseline), immediate after injection, 4 weeks, 8 weeks, 4 months and 6 months after injection |
| Patient Satisfaction Score (PSS) | a self reported measure of a patient's overall satisfaction with care, a 5 point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied). | within 15 minutes after the procedure completion |
| Time to first postoperative analgesic dose | interval (in hours) from completion of the sacroiliac joint injection to the patient's first request for analgesia recorded by nursing staff then patient and his relatives after discharge. A longer time to first dose indicates more prolonged analgesic effect of the injection. | interval (in hours) for the first 48 hours |
| Cumulative Gabapentin consumption | 1 week, 4 weeks, 8 weeks, 4 months and 6 months after injection. |
| Procedure discomfort | Procedure discomfort via VAS scale | within 15 minutes after the procedure completion |
| Complications | I. Postoperative Nausea and Vomiting (PONV). II. Hyperalgesia III. Loss of Sensation IV. Lower Limb Muscle Weakness V. Infection at Injection Site | six months after injection |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009422 | Nervous System Diseases |